Robert J. Palay, JD, MBA
Chairman of the Board
Mr. Palay is one of our founders and has served as Chairman of the Board and as Chief Executive Officer since 2007. Mr. Palay previously served as chairman of the board and chief executive officer of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc., a molecular biology tools company, and served as its chairman of the board from 1999 to 2007 and as its chief executive officer from 1999 to 2000. Since their inception, Mr. Palay has served as a manager of the general partner or manager of each of the various Tactics II entities, which are private investment vehicles and are among our principal shareholders. He received a A.B., magna cum laude, from Harvard College, an M.M. from the J.L. Kellogg Graduate School of Management and a J.D. from the Northwestern University School of Law.
Thomas M. Palay, JD, PhD
Vice Chairman of the Board
Dr. Palay is one of our founders and has served as Vice Chairman of the Board and as President since 2007. Dr. Palay previously served as vice chairman of the board and president of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc. and served as its vice chairman of the board, vice president and chief operating officer from 1999 to 2007. Since their inception, Dr. Palay has served as a manager of the general partner or manager of each of the Tactics II entities. Dr. Palay joined the faculty of the University of Wisconsin Law School in 1980. He retired as the Foley & Lardner–Bascom Professor of Law in 2010. Dr. Palay received a B.A., summa cum laude, from Tufts University, a J.D. from the University of Pennsylvania and a Ph.D. from the University of Pennsylvania.
Michael Falk, JD, MBA, MS
Mr. Falk has served on our board of directors since 2010 and as general counsel for WARF, the patent management and licensing organization for the University of Wisconsin-Madison, since 2007. At WARF, Mr. Falk oversees the legal and intellectual property professionals and is part of WARF’s executive management team. He also serves on the foundation’s investment risk committee. Before joining WARF, Mr. Falk practiced as a patent litigator with Foley & Lardner LLP. He received a B.A. from Columbia University and a J.D., an MBA and a MS in microbiology from the University of Wisconsin-Madison.
Craig T. January, MD, PhD
Dr. January is one of our founders and has served on our board of directors since 2008. Since 1981, he has served as a practicing cardiologist and, since 1995, a professor in the Department of Medicine in the Division of Cardiovascular Medicine at the University of Wisconsin-Madison, School of Medicine and Public Health. Dr. January has consulted to multiple large and small pharmaceutical companies and was one of the first scientists to stably express hERG potassium channels in a human cell system. He received an MD and a Ph.D. in Physiology and Biophysics from the University of Iowa.
Kenneth C. Hunt, JD
Mr. Hunt has served on our board of directors since 2009. He has also served as senior vice president, general counsel and secretary of ManpowerGroup Inc., a world leader in the employment services industry, from 2008 until January 2013. Prior to joining ManpowerGroup, Mr. Hunt was a shareholder at Godfrey & Kahn, S.C. from 1981 to 2007. He received a degree in Aerospace Engineering from the University of Michigan and a J.D., with distinction, from Duke University Law School.
Gregory Lynch, JD
Mr. Lynch has served on our board of directors since 2009. At Michael Best & Friedrich LLP, Mr. Lynch led the venture capital practice from 2005 to 2010 and the corporate group from 2010 to the present. Mr. Lynch has over 15 years' experience advising high-growth companies on strategic financing, operational and corporate governance matters from start-up through sale or initial public offering. He received a BSBA in Finance and Economics from Creighton University and J.D. from the University of Iowa, where he achieved Order of the Coif distinction.
Stanley Rose, PhD
Dr. Rose has served on our board of directors since 2009. Dr. Rose has served as president of Rose Ventures, Inc., a Wisconsin-based firm that provides consulting services and makes investments in life science tool companies, since its founding in 2008. Dr. Rose has served as director of Invenra since 2012 and as director since 2009 and as chief commercial officer since 2011 of Nabsys, a portfolio company of Point Judith Capital. He also served as president, chief executive officer and a member of the board of directors of NimbleGen Systems, Inc. from 2003 to 2007, continuing on until 2008 as chief executive officer of Roche NimbleGen following Roche's acquisition of NimbleGen Systems, Inc. in 2007. Prior to NimbleGen Systems, Inc., Dr. Rose co-founded Genetic MicroSystems, a microarray instruments company, in 1997. Dr. Rose received a B.A. from Cornell University and a Ph.D. in Biology from the Massachusetts Institute of Technology.
James A. Thomson, VMD, PhD
James A. Thomson, VMD, Ph.D. Dr. Thomson is one of our founders and has served as our Chief Scientific Officer and as a member of our board of directors since 2007. He received a VMD and a Ph.D. from the University of Pennsylvania. He is a member of the National Academy of Sciences, and has served as the Director of Regenerative Biology at the Morgridge Institute for Research since 2008 and as the John D. MacArthur Professor of Anatomy at the University of Wisconsin-Madison since 2003. Dr. Thomson’s derivation of human ES cells was featured as Science Magazine’s “Scientific Breakthrough of the year” in 1999, and work from Dr. Thomson’s laboratory has been cited in TIME Magazine's “Top 10 Discoveries of the Year” on three separate occasions, including the isolation of human ES cells (1998), the isolation of human iPS cells (2007) and the collaborative mapping of the human epigenome (2009). He was featured on the cover of TIME Magazine’s “America’s Best in Science and Medicine” in 2001, and in 2007 was named one of TIME Magazine’s “100 Most Influential People in the World.” Dr. Thomson has published over 150 scientific, peer-reviewed papers and has been an inventor on 30 issued patents.
Michael Van Handel, MBA
Mr. Van Handel has served on our board of directors since 2010. He has also served on the board of directors of the Milwaukee Youth Symphony Orchestra since 2005 and BMO Financial Corp. since 2011. He previously served on the board of directors of Harris Financial Corp. from 2006 to 2011. Mr. Van Handel has served as a vice president, since 1991, and the chief financial officer, since 1998, of ManpowerGroup Inc. Mr. Van Handel received a B.S. in Accounting from Marquette University and an MBA in Banking and Finance from the University of Wisconsin.